Nonselective Intra-arterial CT Angiography Versus Selective Digital Subtraction Angiography for Detecting Neovascularization During Transarterial Embolization for Adhesive Capsulitis
摘要
Transarterial embolization (TAE) for adhesive capsulitis requires precise detection of periarticular neovascularization, which is often inconspicuous on digital subtraction angiography (DSA). This study compared intra-arterial CT angiography (IA-CTA) with DSA for detecting synovial neovascularization during embolization.
Materials and MethodsIn this prospective single-center study, 21 participants with adhesive capsulitis despite ≥ 3 months of conservative treatment were enrolled. Nonselective IA-CTA was performed from the mid-subclavian artery before selective DSA-guided embolization in a hybrid angio-CT suite. Six periarticular sites per shoulder were evaluated. Two radiologists independently assigned five-point scores for IA-CTA and DSA to establish the reference standard using a multimodality adjudication rule. Six radiology residents independently scored each modality. Diagnostic performance was compared using multireader multicase analysis; secondary endpoints were sensitivity, specificity, and reader agreement.
ResultsTwenty-one participants (mean age, 61.6 ± 11.0 years; 15 women, 6 men) were included. Of 126 periarticular sites, 65 (51.6%) were positive by the reference standard. Reader-averaged area under the receiver operating characteristic curve (AUC) favored IA-CTA over DSA (0.901 vs. 0.769; p < 0.01). At the prespecified positivity threshold (score ≥ 4), reader-averaged sensitivity was 68.5% (95% CI: 57.0–79.7) with IA-CTA and 47.9% (95% CI: 36.9–57.7) with DSA (p = 0.01), whereas specificity was 95.4% (95% CI: 90.8–99.0) with IA-CTA and 92.3% (95% CI: 86.2–97.4) with DSA (p = 0.24). Inter-reader agreement favored IA-CTA over DSA (weighted κ 0.75 vs. 0.65; p < 0.01).
ConclusionNonselective IA-CTA showed higher diagnostic performance, higher sensitivity, and better inter-reader agreement than selective DSA for detecting synovial neovascularization.
Level of EvidenceLevel 4, diagnostic study. (ClinicalTrials.gov: NCT06509087)
Graphical abstract